RXi Pharmaceuticals Granted Patents for sd-rxRNA Technology Strengthening Intellectual Property Estate in Europe and Japan

MARLBOROUGH, Mass., Aug. 2, 2018 /PRNewswire/ — RXi Pharmaceuticals Corporation (NASDAQ: RXII) a biotechnology company developing the next generation of immuno-oncology therapeutics based on its prop…
( read original story …)


Related Post

Lotte DF Japan expansion ‘includes Fukuoka and Osa...
views 222
“At this point, we are planning to expand our busi...
Small Japanese banks offered lending lifeline
views 297
The Japanese export credit agency, the Japan Bank ...
Tokyo Stock Exchange Opens Strong
views 93
TOKYO, NNC -- Tokyo stocks opened higher on Friday...
Taxi companies line up to overhaul Japan’s staid c...
views 197
“Clearly we need a different way of doing business...
Japanese Businessman Promises $50 Billion and 50,0...
views 237
President-elect Donald Trump made an announcement ...
Osaka or Kyoto? Where to stay as a base for Kansai...
views 193
Certainly, Osaka will be more geared up to accommo...
China, Japan resume economic talks after 8-year hi...
views 122
TOKYO — China and Japan resumed high-level economi...
Japan Christian sites added to UNESCO World Herita...
views 77
A dozen Christian locations in parts of southern J...
Japan earthquake: small tsunami strike Fukushima c...
views 235
A powerful earthquake off the northeast Japanese c...
Trump's Florida estate stirs ethics debate as...
views 273
He has described the sprawling Mar-a-Lago property...